As a potent metabolic regulator, FGF21 has been closely related to obesity-related disorders, such as hyperglycemia, dyslipidemia, insulin resistance, and hepatosteatosis [5–8]. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.